|
JPS5967214A
(ja)
*
|
1982-10-12 |
1984-04-16 |
Kazuo Suga |
化粧品組成物
|
|
DE3380342D1
(en)
*
|
1982-10-26 |
1989-09-14 |
Cta Finanz Ag |
Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals
|
|
IT1170215B
(it)
*
|
1983-09-12 |
1987-06-03 |
Crinos Industria Farmaco |
Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
|
|
IT1170214B
(it)
*
|
1983-09-12 |
1987-06-03 |
Crinos Industria Farmaco |
Composizione farmaceutica per la cura delle arteriopatie periferiche
|
|
IT1206341B
(it)
*
|
1984-02-16 |
1989-04-14 |
Crinos Industria Farmaco |
Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
|
|
IT1187833B
(it)
*
|
1985-12-12 |
1987-12-23 |
Farmigea Spa |
Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo
|
|
IT1190313B
(it)
*
|
1986-04-17 |
1988-02-16 |
Crinos Industria Farmaco |
Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
|
|
IT1212143B
(it)
|
1987-06-26 |
1989-11-08 |
Crinos Industria Farmaco |
Composizione ad attivita'tricogena.
|
|
IT1222701B
(it)
*
|
1987-09-23 |
1990-09-12 |
Crinos Industria Farmaco |
Composizione ad uso topico avente attivita' tricogena,antiforfora ed antiseborroica
|
|
IT1223322B
(it)
*
|
1987-10-23 |
1990-09-19 |
Crinos Industria Farmaco |
Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
|
|
IT1231509B
(it)
*
|
1989-09-07 |
1991-12-07 |
Crinos Industria Farmaco |
Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
|
|
US5977083A
(en)
*
|
1991-08-21 |
1999-11-02 |
Burcoglu; Arsinur |
Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
|
|
US6699985B2
(en)
*
|
1991-08-21 |
2004-03-02 |
Arsinur Burcoglu |
Method of treating HIV infection and related secondary infections thereof
|
|
IT1252174B
(it)
*
|
1991-12-09 |
1995-06-05 |
Crinos Industria Farmaco |
Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
|
|
US7683035B1
(en)
|
1999-02-23 |
2010-03-23 |
Qiagen, Gmbh |
Method of stabilizing and/or isolating nucleic acids
|
|
DE69928778T2
(de)
|
1999-06-08 |
2006-07-06 |
Gentium S.P.A., Villa Guardia |
Anwendung von Komplexen von kationischen Liposomen und Polydeoxyribonukleotiden wie Arzneimitteln
|
|
US6323743B1
(en)
*
|
1999-08-24 |
2001-11-27 |
Tresness Irrevocable Patent Trust |
Electronic filter assembly
|
|
EP1147777A1
(en)
*
|
2000-04-18 |
2001-10-24 |
Crinos Industria Farmacobiologica S.p.A. |
Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
|
|
US8771663B2
(en)
*
|
2000-04-18 |
2014-07-08 |
Gentium Spa |
Formulation having mobilising activity
|
|
ITMI20031714A1
(it)
*
|
2003-09-05 |
2005-03-06 |
Gentium Spa |
Formazioni ad azione antitumorale.
|
|
WO2006094916A1
(en)
*
|
2005-03-03 |
2006-09-14 |
Gentium Spa |
Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors
|
|
EP1872787A1
(en)
*
|
2006-06-27 |
2008-01-02 |
Gentium S.p.A. |
Use of defibrotide for the inhibition of heparanase
|
|
EP1982722A1
(en)
*
|
2007-04-16 |
2008-10-22 |
Gentium S.p.A. |
Use of oligotide for the treatment of renal diseases
|
|
EP2103689A1
(en)
|
2008-03-19 |
2009-09-23 |
Gentium S.p.A. |
Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
|
|
JP6069209B2
(ja)
|
2010-11-12 |
2017-02-01 |
ジェンティウム ソシエタ ア レスポンサビリタ リミタータ |
移植片対宿主病（ｇｖｈｄ）の予防および／または治療に使用するためのデフィブロタイド
|
|
JP6198821B2
(ja)
|
2012-06-22 |
2017-09-20 |
ゲンチウム エス．アール．エル． |
デフィブロチドの生物学的活性を決定する為の、ユーグロブリンに基づく方法
|
|
EP3026122A1
(en)
|
2014-11-27 |
2016-06-01 |
Gentium S.p.A. |
Cellular-based method for determining the potency of defibrotide
|
|
MX2020001337A
(es)
|
2017-08-03 |
2020-09-09 |
Jazz Pharmaceuticals Ireland Ltd |
Formulaciones que comprenden un acido nucleico en una alta concentracion.
|
|
MX2020010689A
(es)
|
2018-04-12 |
2021-01-20 |
Jazz Pharmaceuticals Inc |
Defibrotida para la prevencion y tratamiento del sindrome de liberacion de citocinas y la neurotoxicidad asociada con la inmunodeplecion.
|
|
US20220023533A1
(en)
|
2018-12-07 |
2022-01-27 |
Jazz Phrmaceticals Ireland Limited |
Subcutaneous delivery of high concentration formulations
|
|
WO2021174039A1
(en)
|
2020-02-28 |
2021-09-02 |
Jazz Pharmaceuticals Ireland Limited |
Delivery of low viscosity formulations
|
|
EP4135717A1
(en)
|
2020-04-17 |
2023-02-22 |
Jazz Pharmaceuticals Ireland Limited |
Defibrotide treatment for the prevention of organ rejection and injury
|
|
WO2022234101A1
(en)
|
2021-05-06 |
2022-11-10 |
Jazz Pharmaceuticals Ireland Limited |
Defibrotide for the treatment and prevention of acute respiratory distress syndrome
|